|
|
Inpatient and Outpatient Orderable
CSF Paraneoplastic Autoantibody Evaluation
Synonyms
|
- LAB11498
- PARANCSF
- PARANEOPLASTIC AB EVAL, CSF
- PARANEOPLASTIC AUTOANTIBODY EVALUATION, SPINAL
|
Cerner Name
|
Paraneoplastic AB Eval, CSF
|
Clinical Info
|
Aids in the diagnosis of paraneoplastic neurological autoimmune disorders related to carcinoma of lung, breast, ovary, thymoma, or Hodgkin lymphoma in spinal fluid specimens
|
Specimen Sources
|
Lumbar Puncture
|
Specimen Types
|
Cerebrospinal Fluid
|
Container
|
Sterile
|
Collection Instructions
|
Container/Tube: Sterile vial
Specimen : 4 mL CSF (2 mL min)
Transport Temperature: Refrigerated
Stability:
Refrigerated (preferred) - 28 days
Frozen - 28 days
Ambient - 72 hours
|
Specimen Volume
|
4 mL CSF (2 mL min)
|
Transport Instructions
|
Refrigerated
|
Specimen Stability
|
Refrigerated (preferred) - 28 days
Frozen - 28 days
Ambient - 72 hours
|
Methodology
|
ANN1C, ANN2C, ANN3C, PCA1C, PCA2C, PCTRC, AMPHC, CRMC, AGN1C,
NMDIC, AMPIC, GABIC, DPPIC, DPPTC, GL1IC, GL1TC: Indirect
Immunofluorescence Assay (IFA)
WBNC, ABLTC, CRMWC: Western Blot
VGKCC: Radioimmunoassay (RIA)
DPPCC, NMDCC, AMPCC, GABCC, GL1CC, LG1CC, CS2CC: Cell-Binding
Assay (CBA)
GD65C: Immunoprecipitation Assay (IPA)
|
Days Performed
|
AGN1C, ANN1C, ANN2C, ANN3C, PCA1C, PCA2C, PCTRC, AMPHC, CRMC,
AMPIC: Monday through Friday; 11:30 a.m. and 8 p.m.; Saturday,
Sunday; 8 a.m.
WBNC, CRMWC, ABLTC: Monday, Wednesday, Friday; 8 a.m.
NMDCC, AMPCC, GABCC, LG1CC, CS2CC: Monday through Friday; 6
a.m.
DPPCC, GL1CC: Monday through Thursday, Sunday; 6 p.m.
GD65C: Monday through Friday; 6 a.m. and 4 p.m.
VGKCC: Monday through Friday 11 a.m. and 6 p.m.; Saturday,
Sunday 6 a.m.
|
Performing Laboratory
|
Mayo Medical Laboratories
|
CPT
|
86255 x 9
83519 (if appropriate)
84182 x 3 (if appropriate)
86255 x 9 (if appropriate)
86256 x 5 (if appropriate)
86341 (if appropriate)
;
|
PDM
|
1659071
|
Only Orderable at Locations:
|
Orderable Everywhere
|
Results
|
| Component Name |
Base Name |
Common Name |
External Name |
| PARANEOPLASTIC INTERPRETATION, CSF |
PARAINTCSF |
PARANEOPLASTIC INTERPRETATION, CSF |
Paraneoplastic Interpretation, CSF |
| IFA NOTES |
IFANOTES |
IFA NOTES |
IFA Notes |
| AMPHIPHYSIN AB, CSF |
AMPHIPHYABC |
AMPHIPHYSIN AB, CSF |
Amphiphysin Ab, CSF |
| ANTI-GLIAL NUCLEAR AB, TYPE 1 |
GLIALNUCAB1 |
ANTI GLIAL NUCLEAR AB, TYPE 1 |
AGNA-1, CSF |
| ANTI-NEURONAL NUCLEAR AB, TYPE 1 |
ANNAB1 |
ANTI NEURONAL NUCLEAR AB, TYPE 1 |
ANNA-1, CSF |
| ANTI-NEURONAL NUCLEAR AB, TYPE 2 |
ANNAB2 |
ANTI NEURONAL NUCLEAR AB, TYPE 2 |
ANNA-2, CSF |
| ANTI-NEURONAL NUCLEAR AB, TYPE 3 |
ANNAB3 |
ANTI NEURONAL NUCLEAR AB, TYPE 3 |
ANNA-3, CSF |
| CRMP-5-IGG, CSF |
CRMP5IGGCSF |
CRMP 5 IGG, CSF |
CRMP-5-IgG, CSF |
| PURKINJE CELL CYTOPLASMIC AB TYPE 1 |
PURCYTO1 |
PURKINJE CELL CYTOPLASMIC AB TYPE 1 |
PCA-1, CSF |
| PURKINJE CELL CYTOPLASMIC AB TYPE 2 |
PURCYTO2 |
PURKINJE CELL CYTOPLASMIC AB TYPE 2 |
PCA-2, CSF |
| PURKINJE CELL CYTOPLASMIC AB TYPE TR |
PURCYTOTR |
PURKINJE CELL CYTOPLASMIC AB TYPE TR |
PCA-Tr, CSF |
|
Result Interpretation
See Report and Algorithum
|
Forms
|
|
LAB11498
|
